[86] documented that RG7834, a novel oral HBV gene expression inhibitor, could reduce the amounts of viral proteins and lessen viremia. RG7834 is a little-molecule compound belonging to the dihydroquinolizinones chemical course just like RNAi but by means of a special system. We also shown that AZD4547, administered for 10 https://pablor631hmq4.livebloggs.com/profile